Ann: Commercial Scale Manufacturing of Efti for Clinical Trials, page-29

Let's have a bit of fun... potential earnings from current production facility.......
Not to be taken any notice of......

Equipment...2000L bioreactor....
dosages per batch of 30ml = 66,666 dosages..
lets attribute 666 to wastage with packaging etc.
therefore 66,000 doses available for sale per batch....
Batching time including making bioreactor ready for next batch = 2 weeks
therefore 26 batches per year, lets make it 25 with a bit of time allowed for servicing of bioreactor...
Yearly production therefore is 25 batches of 66,000 doses = 1,650,000 doses per annum....
Cost to buyer per 30ml dose = $100 =return of $165,000,000 per annum to company...
less costs, labor, materials and outgoings = $10,000,000
Earnings per reactor per annum = $155,000,000

all figures plucked from midair and of no relevance except for the exercise by a bloke with too much time on his hands...